EP3920713A4 - Compositions et procédés pour détecter une maladie gastro-intestinale - Google Patents

Compositions et procédés pour détecter une maladie gastro-intestinale Download PDF

Info

Publication number
EP3920713A4
EP3920713A4 EP20752596.5A EP20752596A EP3920713A4 EP 3920713 A4 EP3920713 A4 EP 3920713A4 EP 20752596 A EP20752596 A EP 20752596A EP 3920713 A4 EP3920713 A4 EP 3920713A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
gastrointestinal disease
detecting gastrointestinal
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP20752596.5A
Other languages
German (de)
English (en)
Other versions
EP3920713A1 (fr
Inventor
Sunyoung Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Louisiana State University
Original Assignee
Louisiana State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/267,120 external-priority patent/US11493515B2/en
Application filed by Louisiana State University filed Critical Louisiana State University
Publication of EP3920713A1 publication Critical patent/EP3920713A1/fr
Publication of EP3920713A4 publication Critical patent/EP3920713A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/195Antibiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/06Gastro-intestinal diseases
    • G01N2800/065Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Husbandry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
EP20752596.5A 2019-02-04 2020-02-04 Compositions et procédés pour détecter une maladie gastro-intestinale Withdrawn EP3920713A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16/267,120 US11493515B2 (en) 2016-08-04 2019-02-04 Compositions and methods to detect gastrointestinal disease
PCT/US2020/016646 WO2020163381A1 (fr) 2019-02-04 2020-02-04 Compositions et procédés pour détecter une maladie gastro-intestinale

Publications (2)

Publication Number Publication Date
EP3920713A1 EP3920713A1 (fr) 2021-12-15
EP3920713A4 true EP3920713A4 (fr) 2022-11-09

Family

ID=83366685

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20752596.5A Withdrawn EP3920713A4 (fr) 2019-02-04 2020-02-04 Compositions et procédés pour détecter une maladie gastro-intestinale

Country Status (5)

Country Link
EP (1) EP3920713A4 (fr)
CN (2) CN120102879A (fr)
AU (1) AU2020217717B2 (fr)
CA (1) CA3128826A1 (fr)
WO (1) WO2020163381A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114113624B (zh) * 2020-08-28 2024-08-16 香港城市大学深圳研究院 利用免疫球蛋白关联蛋白质组开发疾病标志物的方法及装置
US11741686B2 (en) 2020-12-01 2023-08-29 Raytheon Company System and method for processing facility image data
WO2023141560A2 (fr) * 2022-01-20 2023-07-27 Synthetic Biologics, Inc. Phosphatase alcaline destinée à être utilisée en oncologie
CN116662798B (zh) * 2023-04-23 2026-02-24 迪辅乐生物(上海)有限公司 基于肠型分型的微生物组合物、过敏预测模型的构建方法及其模型和应用
WO2025075652A1 (fr) * 2023-10-06 2025-04-10 DeLorean Artificial Intelligence, Inc. Système et méthode de gestion de soins médicaux
CN120673884B (zh) * 2025-08-20 2025-11-04 温州医科大学 基于ai的克林霉素磷酸酯加工水解优化方法及系统

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018027179A1 (fr) * 2016-08-04 2018-02-08 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compositions et méthodes pour détecter une maladie gastro-intestinale

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006026383A2 (fr) * 2004-08-26 2006-03-09 Strategic Health Decisions, Inc. Systeme pour optimiser les strategies de traitement au moyen d'un systeme d'evaluation specifique du patient
US20140162370A1 (en) * 2011-06-14 2014-06-12 The Board Of Trustees Of The Leland Stanford Junior University Urine biomarkers for necrotizing enterocolitis and sepsis
US10950353B2 (en) * 2013-09-20 2021-03-16 Georgia Tech Research Corporation Systems and methods for disease progression modeling
BR112017014419A2 (pt) * 2015-01-09 2018-01-16 S Malo Madhu diagnose e tratamento de diabetes incipiente
CN108061556B (zh) * 2017-10-18 2021-07-09 广州傲胜机器人科技有限公司 一种基于隐马尔可夫模型的地图匹配方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018027179A1 (fr) * 2016-08-04 2018-02-08 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compositions et méthodes pour détecter une maladie gastro-intestinale
US20190257833A1 (en) * 2016-08-04 2019-08-22 The Board Of Supervisors Of Louisiana State University And Agricultural And Meo Compositions and methods to detect gastrointestinal disease

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
EATON SIMON ET AL: "Current research in necrotizing enterocolitis", EARLY HUMAN DEVELOPMENT, SHANNON, IR, vol. 97, 28 February 2016 (2016-02-28), pages 33 - 39, XP029538630, ISSN: 0378-3782, DOI: 10.1016/J.EARLHUMDEV.2016.01.013 *
HEATH MAYA ET AL: "Association of Intestinal Alkaline Phosphatase With Necrotizing Enterocolitis Among Premature Infants", JAMA NETWORK OPEN, vol. 2, no. 11, 1 November 2019 (2019-11-01), pages e1914996, XP055965856, Retrieved from the Internet <URL:https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2754257> DOI: 10.1001/jamanetworkopen.2019.14996 *
KAMPANATKOSOL RICHARD ET AL: "The relationship between reticulated platelets, intestinal alkaline phosphatase, and necrotizing enterocolitis", JOURNAL OF PEDIATRIC SURGERY, W. B. SAUNDERS COMPANY, US, vol. 49, no. 2, 21 November 2013 (2013-11-21), pages 273 - 276, XP028612932, ISSN: 0022-3468, DOI: 10.1016/J.JPEDSURG.2013.11.037 *
WHITEHOUSE J S ET AL: "The Protective Role of Intestinal Alkaline Phosphatase in Necrotizing Enterocolitis", JOURNAL OF SURGICAL RESEARCH, ACADEMIC PRESS INC., SAN DIEGO, CA, US, vol. 163, no. 1, 1 September 2010 (2010-09-01), pages 79 - 85, XP027212279, ISSN: 0022-4804, [retrieved on 20100521] *

Also Published As

Publication number Publication date
CN113645846B (zh) 2025-02-25
CN113645846A (zh) 2021-11-12
CN120102879A (zh) 2025-06-06
EP3920713A1 (fr) 2021-12-15
AU2020217717B2 (en) 2026-03-12
CA3128826A1 (fr) 2020-08-13
WO2020163381A1 (fr) 2020-08-13
AU2020217717A1 (en) 2021-09-30

Similar Documents

Publication Publication Date Title
EP3920713A4 (fr) Compositions et procédés pour détecter une maladie gastro-intestinale
EP4139348A4 (fr) Procédés et compositions pour le traitement d&#39;une inflammation associée à un virus
MA54875A (fr) Compositions oligonucléotidiques et procédés associés
EP3952914A4 (fr) Procédés et compositions pour une dégradation de protéine ciblée
EP4045898A4 (fr) Imagerie de luminescence pour la détection
MA52208A (fr) Biomarqueurs pour une maladie du greffon contre l&#39;hôte
EP3720458A4 (fr) Procédés et compositions pour prévenir une infection microbienne
EP3876750A4 (fr) Procédés de soutien de l&#39;homéostasie gastro-intestinale
EP3678640A4 (fr) Procédés et compositions pour traiter une maladie cutanée inflammatoire
EP3423128A4 (fr) Ancrages pyloriques et procédés pour manchons de court-circuit intestinal
KR102223657B9 (ko) 염증성 장질환 예방 또는 치료용 약학적 조성물
EP2283119A4 (fr) Procédés et compositions pour induire une adipogenèse brune
EP3635100A4 (fr) Compositions et procédés pour exprimer l&#39;otoferline
EP3273944A4 (fr) Compositions et procédés permettant d&#39;administrer des agents de type biomacromolécule
EP3793562A4 (fr) Procédés et compositions pour inhiber la dihydroorotate déshydrogénase
EP3446123A4 (fr) Procédés et compositions pour pronostiquer une naissance prématurée
EP3298151A4 (fr) Procédés et compositions pour déterminer le ph
EP3803403A4 (fr) Compositions et procédés d&#39;imagerie
MA44864A (fr) Trithérapie pour le traitement d&#39;une maladie intestinale inflammatoire
EP2247291A4 (fr) Procédés et compositions pour traiter une infection intestinale inflammatoire
EP3289064A4 (fr) Compositions et procédés pour la détection d&#39;allergènes
EP3938783A4 (fr) Procédés pour maladie cardiovasculaire en cas de polyarthrite rhumatoïde
EP3373950A4 (fr) Procédés et compositions d&#39;évaluation de spécificités d&#39;anticorps
EP3807319A4 (fr) Compositions et procédés pour induire une phagocytose
EP3735457A4 (fr) Compositions et procédés pour produire des mégacaryocytes

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210901

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40064344

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20221010

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 29/00 20060101ALI20221004BHEP

Ipc: A61P 1/00 20060101ALI20221004BHEP

Ipc: A23L 33/00 20160101ALI20221004BHEP

Ipc: A23L 33/17 20160101ALI20221004BHEP

Ipc: A23K 20/195 20160101ALI20221004BHEP

Ipc: C12Q 1/42 20060101ALI20221004BHEP

Ipc: A61K 9/00 20060101ALI20221004BHEP

Ipc: A23C 9/12 20060101AFI20221004BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20250124

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20250725